SwimCount
SwimCount, a Denmark-based diagnostic company, sells the world's first patented at-home sperm quality test that measures Progressive Motile Sperm Cells (PMSCs) for individual men and couples assessing fertility, distributed via Amazon, major US retailers, and healthcare wholesalers across 25+ countries.
- Company typePrivate
- Founded2011
- HeadquartersCopenhagen, Denmark
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
SwimCount firmographics
Firmographics- Name
- SwimCount
- Legal name
- MotilityCount ApS
- Website
- https://swimcount.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- SwimCount, a Denmark-based diagnostic company, sells the world's first patented at-home sperm quality test that measures Progressive Motile Sperm Cells (PMSCs) for individual men and couples assessing fertility, distributed via Amazon, major US retailers, and healthcare wholesalers across 25+ countries.
- Ownership category
- akta.pro rank
Where SwimCount is headquartered
LocationHeadquarters
- HQ city
- Copenhagen
- HQ country
- Denmark
- HQ region
- Europe
Offices1 record
Markets served
SwimCount business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Marketing or Sales, Operations, Personnel
Revenue model
- At-Home Fertility Test Kit Sales: SwimCount generates revenue through one-time sales of its SwimCount Sperm Quality Test kit, which includes the patented test device, semen collection cup, transfer syringe, and instructions in English and Spanish. The product is sold through online retailers (Amazon), physical retail chains (H-E-B), and healthcare distributors (McKesson, Cardinal Health, Anda).
Go-to-market motion2 records
Distribution channels6 records
Marketing channels4 records
SwimCount product offering
Product offeringCore offering
SwimCount manufactures and sells the SwimCount® Sperm Quality Test, an at-home diagnostic kit that measures the concentration of Progressive Motile Sperm Cells (PMSCs) using a patented three-chamber Membrane Swim-Up Technology. The kit includes the patented test device, a semen collection cup, a transfer syringe, and English/Spanish instructions, producing a colorimetric result in approximately 30 minutes with a clinically proven accuracy of 91.88%. The test is FDA-cleared (2019) and CE-marked (2015), and is sold directly to male consumers for pre-screening fertility status at home.
Differentiator
Problem solved
Functional benefit
Products and services
- SwimCount® Sperm Quality Test An at-home diagnostic test kit for male fertility that measures the concentration of Progressive Motile Sperm Cells (PMSCs), the only sperm cells capable of fertilizing an egg. Uses a patented three-chamber Membrane Swim-Up Technology to separate, stain, and detect PMSCs via color intensity, with results in 30 minutes and 91.88% clinically proven accuracy. Targets individual male consumers seeking an early, private pre-screening of fertility status at home.
Quantifiable outcome
- 91.88% clinically proven accuracy rate
- +1 more outcomes
Companies that use SwimCount
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles1 record
SwimCount technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
SwimCount partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- 2SancoreIn 2022, SwimCount partnered with 2San, an accelerator of innovation in home healthcare, to scale the SwimCount brand. 2San brings products from concept to consumer, backed by industry best practices and subject-matter experts. This partnership enabled SwimCount to achieve wide retail availability across the US. SwimCount is now part of the 2San family of brands, with 2San disclosing it uses Amazon Web Services for processing test results and its privacy policy applies to 2san products. 2San operates global offices in UK, Denmark, Australia, US, Canada, and California.
Scale indicators2 records
SwimCount competitors and assessment
Company assessmentBroad incumbents
- Ro: Large direct-to-patient healthcare company offering men's health services including fertility, testosterone, and weight loss. Operates a broader platform that includes male fertility testing, overlapping with SwimCount's target segment at a portfolio scale.
- Clearblue: Established global brand for at-home reproductive health tests (primarily ovulation and pregnancy). Operates in the same consumer at-home fertility category as SwimCount but on the female side, with much larger retail presence and brand awareness.
Emerging players
- Proov: At-home diagnostics company focused on female reproductive health, including ovulation and PdG testing. While focused on the female side, Proov operates in the same home fertility diagnostics category and shares retail channels (Amazon, DTC) with SwimCount.
Direct peers
- Dadi: At-home sperm testing and storage service with subscription-based reporting and long-term fertility monitoring. Competes with SwimCount in at-home male fertility assessment while offering optional cryopreservation as an extension.
- Legacy: Direct-to-consumer at-home male fertility testing service offering sperm analysis with mail-in kits, app-based results, and optional cryopreservation. Targets the same male fertility assessment use case as SwimCount but with a recurring service model and broader digital engagement.
- YO Home Sperm Test (Medical Electronic Systems): FDA-cleared at-home sperm test that pairs a smartphone-based device with an app to assess sperm motility and count. Directly competes with SwimCount as an FDA-cleared, at-home male fertility diagnostic for consumer use.
- ExSeed Health: At-home sperm test kit combined with a smartphone camera-based analysis app, providing personalized fertility scores and lifestyle recommendations. Directly competes with SwimCount's at-home PMSC measurement through a digital-first approach.
- Fellow (formerly Sandstone Diagnostics): Maker of the Trak Male Fertility Testing System, an at-home device measuring sperm count, motility, and volume. Targets the same male fertility pre-screening use case as SwimCount through home diagnostics.
- SpermCheck Fertility: FDA-cleared at-home sperm count test kit sold over the counter. Directly competes with SwimCount as an at-home male fertility screening product, though it measures total sperm count rather than progressive motile cells.
Others
- Labcorp: Major clinical laboratory network providing comprehensive semen analysis and fertility diagnostics through physician orders. Represents the clinical alternative to SwimCount's at-home test, and a potential B2B partner or distribution channel.
Market position
Customer concentration
SwimCount social profiles
Digital presenceSwimCount compliance and trust
Trust signalCompliance3 records
SwimCount financial estimates
Financial estimateRevenue estimate
Valuation estimate
SwimCount leadership team
Management profileNumber of profiles
Profiles3 records
SwimCount funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SwimCount M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SwimCount
What does SwimCount do?
SwimCount manufactures and sells the SwimCount® Sperm Quality Test, an at-home diagnostic kit that measures the concentration of Progressive Motile Sperm Cells (PMSCs) using a patented three-chamber Membrane Swim-Up Technology. The kit includes the patented test device, a semen collection cup, a transfer syringe, and English/Spanish instructions, producing a colorimetric result in approximately 30 minutes with a clinically proven accuracy of 91.88%. The test is FDA-cleared (2019) and CE-marked (2015), and is sold directly to male consumers for pre-screening fertility status at home.
Is SwimCount a public or private company?
SwimCount is a private company. It is classified as corporate owned and is currently operating.
When was SwimCount founded?
SwimCount was founded in 2011. It employs 1 to 10 people.
Where is SwimCount based?
SwimCount is headquartered in Copenhagen, Denmark, in the Europe region.
How does SwimCount make money?
One revenue line is on record: at-Home Fertility Test Kit Sales.
Who are SwimCount's main competitors?
Broad incumbents on record are Ro and Clearblue. Proov is listed as an emerging player. Direct peers are Dadi, Legacy, YO Home Sperm Test (Medical Electronic Systems), ExSeed Health, Fellow (formerly Sandstone Diagnostics) and SpermCheck Fertility. Labcorp is listed as an others.
Does SwimCount have an API?
No public API is recorded for SwimCount.